Global postpartum treatment device market is anticipated to rise with a CAGR of about 6.4% for the forecast period of 2021-2030. Rising prevalence of postpartum hemorrhage has boosted the demand for postpartum hemorrhage treatment devices. About 14 million women gets affected from postpartum hemorrhage every year as per WHO.
View moreFeb 2022
115 pages
The Naloxone market is projected to grow at a CAGR of 10.5% during the forecast period from 2021 to 2030. Naloxone is an opioid antagonist designed to rapidly reverse opioid overdose. Naloxone can restore the normal respiration of a person whose breathing has stopped or slowed down due to opioid or heroin overdose. Currently, opioid abuse is one of the foremost causes of drug overdose and is a leading cause of death globally. However, it is more common in North America and Europe. The opioid crisis in the U.S. has reached epidemic proportions, leading to serious healthcare costs and losses of resources.
View moreJan 2022
120 pages
The pharmacovigilance market is projected to grow at a CAGR of 13.5% during the forecast period from 2021 to 2030. Increasing demand from pharmaceutical manufacturers and other intermediaries regarding early identification of drug adversities, growing concerns over drug safety and growing need for compliance with regulatory guidelines have led to emergence of pharmacovigilance services. The market is highly driven by incessant R&D activities, ever-rising production as well as consumption of pharmaceutical drugs worldwide.
View moreJan 2022
111 pages
The neurological diseases treatment market is projected to grow at a CAGR of 5.1% during the forecast period from 2021 to 2030. This market is observed as the most diversified and competitive market comprising large number of players globally. The key driving factors assisting the growth of these two segments are rising prevalence of neurological diseases, incessant development in diagnostic technology, and rising awareness associated with early disease diagnosis through awareness campaigns carried out by governmental or non-governmental organizations.
View moreJan 2022
115 pages
Global orthopedic market is anticipated to grow at a CAGR of about 7% during the forecast period year 2021-2030. Rising cases of musculoskeletal disorders and increasing geriatric population is promoting a strong growth in the market. Increasing research investment in biomedical engineering and 3D healthcare printing are resulting in new product launches into the market.
View moreJan 2022
112 pages
The global bioabsorbable stents market is expected to grow at a significant CAGR of 46.0% during the forecast period of 2021 to 2030. Some of the other factors driving the bio absorbable stents market are strong product pipeline, rising cases of heart failure and diabetes. Rising elderly population is another major factor driving the industry, as this segment of the population suffers from cardiovascular diseases which drives the demand of the stents.
View moreJan 2022
110 pages
The oral ulcer drug market was valued at USD 984.8 Mn by 2019. Rising prevalence of oral infection primarily drives the oral ulcer drug market growth. Furthermore, the flourishing persona care and consumer healthcare segment across the globe further accentuates the market growth.
View moreAug 2020
120 pages
The human tetanus immunoglobulin market was valued at USD 1,061.0 Mn by 2019. Rising prevalence of tetanus prone injuries worldwide primarily drives the human tetanus immunoglobulin market growth. Furthermore, the provision of free and compulsory immunization of children and increasing public health awareness together accentuate the market growth.
View moreAug 2020
110 pages
The amlodipine besylate market was valued at USD 1,049.6 Mn by 2019. Rising prevalence of hypertension worldwide primarily drives the amlodipine besylate market growth. Additionally, the effective implementation of treatment guidelines pertaining to coronary artery disease further accentuates the market growth.
View moreAug 2020
110 pages
The neonatal apnea treatment market was valued at USD 232.7 Mn by 2019. The growing incidence of neonatal apnea in preterm birth babies worldwide primarily drives the market growth. Additionally, the effective implementation of treatment guidelines pertaining to the management and care of neonatal intensive units across the globe further accentuates the market growth.
View moreJul 2020
110 pages
1-518-730-1569
911 Central Ave #268
Albany, NY 12206, USA
